Placebo News and Research

RSS

Honey a better cough remedy than over-the-counter-medicines

Cough has many remedies, but one of the most popular ones is honey, which has been used for centuries. Now, new research claims honey may be a better treatment for cough and colds than over-the-counter medicines.

20 Aug 2020

Researchers identify drug that improves survival in critically ill COVID-19 patients

Researchers at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in rheumatoid arthritis and cancer treatments, tocilizumab, improves hospital survival in critically ill patients admitted to the intensive care unit.

19 Aug 2020

Multivitamin, mineral supplements may bolster the immune system of older adults

Older adults who took a daily multivitamin and mineral supplement with zinc and high amounts of vitamin C in a 12-week study experienced sickness for shorter periods and with less severe symptoms than counterparts in a control group receiving a placebo.

18 Aug 2020

Daily cranberry intake could reduce H. pylori infections

A new clinical trial found consuming cranberry juice containing 44 mg of proanthocyanidins (or "PACs") per 240-mL serving twice daily for eight weeks resulted in a 20% reduction in the H. pylori infection rate in Chinese adult participants, when compared to those consuming lower amounts of juice and a placebo.

18 Aug 2020

Paired associative stimulation promotes walking rehabilitation in paraplegic patient

The simultaneous stimulation of the motor nerves of the brain and limbs (paired associative stimulation) has yielded promising research results.

17 Aug 2020

Wits University begins South African trial of Novavax COVID-19 vaccine

NVX-CoV2373 is produced by the biotech company, Novavax (Maryland, U.S.A). Novavax is a late-stage biotechnology company that develops next-generation vaccines for serious infectious diseases.

17 Aug 2020

FDA approves drug for treatment of neuromyelitis optica spectrum disorder

The U.S. Food and Drug Administration has approved Enspryng (satralizumab-mwge) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults with a particular antibody - patients who are anti-aquaporin-4 or AQP4 antibody-positive.

17 Aug 2020

With COVID vaccine trial, rural Oregon clinic steps onto world stage

From the outside, it appears to be just another suburban allergy clinic, a tidy, tan brick-and-cinder-block building set back from a busy highway and across the road from an auto parts store.

17 Aug 2020

Study demonstrates new stimulation therapy for motor rehabilitation in spinal cord injuries

The simultaneous stimulation of the motor nerves of the brain and limbs (paired associative stimulation) has yielded promising research results. Research conducted at the BioMag Laboratory, operated by the University of Helsinki, Helsinki University Hospital and Aalto University, has previously demonstrated that simultaneous transcranial magnetic stimulation of the brain and electrical stimulation of the limb nerves constitute a useful method of motor rehabilitation in patients suffering from spinal cord injuries.

17 Aug 2020

U.S. scientists to create coronavirus strain for human challenge trials

Now, a team of scientists in the United States plans to create a coronavirus strain that can be used for human challenge trials, a controversial type of study wherein health volunteers would be vaccinated and intentionally infected with the virus.

16 Aug 2020

Experimental COVID-19 vaccine prevents severe disease in mice

Now, a novel experimental vaccine that is made from a mild virus genetically-modified to carry an essential gene from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronary disease (COVID-19), has shown promise in preventing pneumonia in mice infected with the virus.

14 Aug 2020

New cell injection technique could help reverse forms of vision loss

University of Toronto Engineering researchers have developed a new method of injecting healthy cells into damaged eyes.

13 Aug 2020

Combination regimen improves overall survival in certain patients with AML

A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.

12 Aug 2020

Experimental vaccine effective at preventing pneumonia in COVID-19-infected mice

An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to a study from Washington University School of Medicine in St. Louis.

12 Aug 2020

Study: Anti-microRNA drug significantly reduces miR-92a levels in human peripheral blood

A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans.

12 Aug 2020

Study: Lipoic acid supplements promote weight loss in certain obese adults

A compound given as a dietary supplement to overweight but otherwise healthy people in a clinical trial caused many of the patients to slim down, research by Oregon State University and Oregon Health & Science University showed.

12 Aug 2020

Mouse study shows potential new way to unlock the power of immunotherapy for cancer patients

Immunotherapy has revolutionized cancer treatment by stimulating the patient's own immune system to attack cancer cells, yielding remarkably quick and complete remission in some cases. But such drugs work for less than a quarter of patients because tumors are notoriously adept at evading immune assault.

11 Aug 2020

1st human data for Sinovac's SARS-CoV-2 CoronaVac vaccine is out

A group of Chinese researchers recently conducted a phase 2 clinical trial to further evaluate the immunogenicity and safety of SARS-CoV-2 inactivated vaccine known as CoronaVac. The results are currently available on the medRxiv preprint server and demonstrate that the vaccine is well tolerated and without any notable dose-related safety concerns, which opens the door for phase 3 clinical trial.

11 Aug 2020

Using medieval medicine to find new treatments for modern-day infections

News-Medical spoke to researchers from the University of Warwick about their research investigating natural antimicrobials and their potential as antibiotics.

11 Aug 2020

COVID-19 Prevention Network announces Phase 3 trials to evaluate monoclonal antibodies

The COVID-19 Prevention Network (CoVPN) today announced two Phase 3 trials to determine whether monoclonal antibodies (mAbs) can prevent SARS-CoV-2, the virus that causes COVID-19.

11 Aug 2020

Placebo News and Research

Honey a better cough remedy than over-the-counter-medicines

Researchers identify drug that improves survival in critically ill COVID-19 patients

Multivitamin, mineral supplements may bolster the immune system of older adults

Daily cranberry intake could reduce H. pylori infections

Paired associative stimulation promotes walking rehabilitation in paraplegic patient

Wits University begins South African trial of Novavax COVID-19 vaccine

FDA approves drug for treatment of neuromyelitis optica spectrum disorder

With COVID vaccine trial, rural Oregon clinic steps onto world stage

Study demonstrates new stimulation therapy for motor rehabilitation in spinal cord injuries

U.S. scientists to create coronavirus strain for human challenge trials

Experimental COVID-19 vaccine prevents severe disease in mice

New cell injection technique could help reverse forms of vision loss

Combination regimen improves overall survival in certain patients with AML

Experimental vaccine effective at preventing pneumonia in COVID-19-infected mice

Study: Anti-microRNA drug significantly reduces miR-92a levels in human peripheral blood

Study: Lipoic acid supplements promote weight loss in certain obese adults

Mouse study shows potential new way to unlock the power of immunotherapy for cancer patients

1st human data for Sinovac's SARS-CoV-2 CoronaVac vaccine is out

Using medieval medicine to find new treatments for modern-day infections

COVID-19 Prevention Network announces Phase 3 trials to evaluate monoclonal antibodies

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News